RapidAI has been cleared for U.S. marketing of updated AI-outfitted software that quickly detects or rules out acute brain hemorrhage on unenhanced CT.

James Udelson, MD, an investigator involved with the PRECISE trial, explained how patient outcomes were improved by 70% from the current standard of care.

Contrary to older research that showed neuroimaging emerging as the single most dominating cost contributor in ischemic stroke care for older Americans, a new study shows treatment and other line items account for bigger slices of the bill.

When COVID-19 social-distancing orders eased across a densely populated county in the southwest, trauma visits spiked 35% over the pre-pandemic normal. This was accompanied by a 17% increase in average daily trauma CT exams.

Leading up to the 2022 RSNA meeting, Signify Research shares the trends and new innovations in CT scanner technology it has seen in recent years.

Bhvita Jani, research manager, Signify Research, explains key trends and technology advances in the computed tomography (CT) market. 

A bipartisan group in the U.S. House is asking CMS to acknowledge the cost-effectiveness of coronary CT angiography by comprehensively covering the exam for patients who present with acute but stable chest pain or other early signs of arterial plaque buildup.

Ricardo Cury, MD, chairman of radiology and director of cardiac imaging, Baptist Health South Florida and Miami Cardiac and Vascular Institute, discusses the new CAD-RADS 2.0 cardiac imaging reporting criteria.